CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Eli Lilly-backed TRex Bio targets up to $133M in U.S. IPO

IPO/OfferingNeutral
AI Analysis

Summary

TRex Bio, backed by Eli Lilly, is targeting up to $133M in a U.S. IPO.

Importance:5/10
Sentiment:
0.00
IPOcapital_raiseEli Lilly backed
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on October 6, 2026 3:49 PM

Read Original